Trial Profile
Effects of IL-1 Beta on the Hypothalamic-pituitary-adrenal (HPA) Axis in Obese Persons - the CortIL-Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Metabolic syndrome
- Focus Therapeutic Use
- Acronyms CortIL
- 22 Aug 2016 Status changed from recruiting to completed.
- 07 Apr 2016 Planned number of patients changed from 69 to 76 as reported by ClinicalTrials.gov record.
- 19 Oct 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.